US Stock MarketDetailed Quotes

LIFE aTyr Pharma

Watchlist
  • 1.720
  • +0.030+1.78%
Close May 9 16:00 ET
  • 1.680
  • -0.040-2.33%
Post 17:26 ET
118.70MMarket Cap-1954P/E (TTM)

aTyr Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3,693.22%-22.38M
20.69%-33.22M
-6.68%-11.06M
22.16%-9.56M
-31.73%-12.01M
94.17%-590K
-26.64%-41.89M
-28.23%-10.37M
-7.07%-12.28M
-18.53%-9.12M
Net income from continuing operations
-29.58%-15.49M
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
-19.52%-12.42M
Operating gains losses
----
93.48%-6K
133.33%7K
--0
----
----
-1,633.33%-92K
--3K
---6K
--0
Depreciation and amortization
1.99%770K
61.71%2.74M
-41.61%407K
139.86%993K
104.90%586K
153.36%755K
29.98%1.7M
117.81%697K
25.84%414K
-20.11%286K
Change In working capital
-172.95%-7.59M
1,902.16%15.01M
185.43%3.52M
680.53%1.1M
-100.74%-17K
787.97%10.41M
67.81%-833K
-744.06%-4.12M
95.88%-190K
21.97%2.3M
-Change in receivables
-95.41%454K
175.94%9.05M
96.18%-458K
-1,808.20%-1.04M
--671K
109,711.11%9.88M
-843.33%-11.92M
-3,819.28%-11.99M
256.41%61K
--0
-Change in prepaid assets
-1,624.43%-7.55M
-72.21%622K
-81.48%632K
173.92%1.48M
-202.01%-1.05M
-137.12%-438K
166.25%2.24M
2,646.27%3.41M
29.38%-2.01M
56.38%-349K
-Change in payables and accrued expense
78.43%-228K
-51.61%3.26M
81.86%3.39M
-49.55%893K
-98.69%38K
-589.35%-1.06M
14,242.55%6.74M
935.00%1.86M
217.06%1.77M
-0.28%2.89M
-Change in other current liabilities
-113.13%-265K
-1.75%2.07M
-101.65%-43K
-1,337.50%-230K
237.24%328K
966.52%2.02M
345.18%2.11M
1,239.91%2.6M
92.69%-16K
-13.81%-239K
Cash from discontinued investing activities
Operating cash flow
-3,693.22%-22.38M
20.69%-33.22M
-6.68%-11.06M
22.16%-9.56M
-31.73%-12.01M
94.17%-590K
-26.64%-41.89M
-28.23%-10.37M
-7.07%-12.28M
-18.53%-9.12M
Investing cash flow
Cash flow from continuing investing activities
96.45%-1.36M
-142.60%-20.13M
791.35%17.82M
-78.77%4.38M
-141.68%-4.16M
-360.99%-38.17M
151.60%47.25M
104.05%2M
239.06%20.65M
350.91%9.97M
Net PPE purchase and sale
98.64%-17K
-187.28%-4.2M
98.48%-17K
-33.89%-557K
-4,390.57%-2.38M
-1,088.89%-1.25M
-929.58%-1.46M
-3,596.88%-1.12M
-581.97%-416K
44.79%-53K
Net investment purchase and sale
96.37%-1.34M
-132.70%-15.93M
472.00%17.84M
-76.55%4.94M
-117.72%-1.78M
-354.66%-36.93M
153.28%48.71M
106.31%3.12M
242.45%21.07M
358.48%10.02M
Cash from discontinued investing activities
Investing cash flow
96.45%-1.36M
-142.60%-20.13M
791.35%17.82M
-78.77%4.38M
-141.68%-4.16M
-360.99%-38.17M
151.60%47.25M
104.05%2M
239.06%20.65M
350.91%9.97M
Financing cash flow
Cash flow from continuing financing activities
-84.38%7.73M
1,115.01%66.23M
557.30%6.03M
-10.99%2.68M
20,458.97%8.02M
3,242.07%49.5M
-95.05%5.45M
3,178.57%918K
-96.41%3.01M
-96.93%39K
Net issuance payments of debt
-83.33%-121K
-496.97%-394K
-74.24%-115K
---108K
---105K
---66K
---66K
---66K
--0
--0
Net common stock issuance
-84.16%7.85M
1,115.63%66.52M
546.46%6.11M
-7.40%2.79M
23,600.00%8.06M
3,248.78%49.56M
-95.02%5.47M
4,873.68%945K
-96.41%3.01M
-97.31%34K
Proceeds from stock option exercised by employees
----
133.33%105K
2.56%40K
--0
----
----
-38.36%45K
333.33%39K
--0
-16.67%5K
Cash from discontinued financing activities
Financing cash flow
-84.38%7.73M
1,115.01%66.23M
557.30%6.03M
-10.99%2.68M
20,458.97%8.02M
3,242.07%49.5M
-95.05%5.45M
3,178.57%918K
-96.41%3.01M
-96.93%39K
Net cash flow
Beginning cash position
97.99%26.03M
462.76%13.15M
-35.73%13.24M
70.68%15.73M
186.88%23.88M
462.76%13.15M
-86.22%2.34M
-65.52%20.6M
320.48%9.22M
-33.87%8.32M
Current changes in cash
-249.11%-16.01M
19.17%12.88M
271.63%12.79M
-121.91%-2.49M
-1,012.43%-8.15M
79.26%10.73M
173.96%10.81M
87.02%-7.45M
-80.22%11.38M
108.59%893K
End cash Position
-58.03%10.02M
97.99%26.03M
97.99%26.03M
-35.73%13.24M
70.68%15.73M
186.88%23.88M
462.76%13.15M
462.76%13.15M
-65.52%20.6M
320.48%9.22M
Free cash flow
-1,119.88%-22.4M
13.99%-37.44M
3.56%-11.08M
20.39%-10.12M
-57.09%-14.41M
81.93%-1.84M
-30.84%-43.53M
-41.76%-11.49M
-10.20%-12.71M
-17.75%-9.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3,693.22%-22.38M20.69%-33.22M-6.68%-11.06M22.16%-9.56M-31.73%-12.01M94.17%-590K-26.64%-41.89M-28.23%-10.37M-7.07%-12.28M-18.53%-9.12M
Net income from continuing operations -29.58%-15.49M-11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M-19.52%-12.42M
Operating gains losses ----93.48%-6K133.33%7K--0---------1,633.33%-92K--3K---6K--0
Depreciation and amortization 1.99%770K61.71%2.74M-41.61%407K139.86%993K104.90%586K153.36%755K29.98%1.7M117.81%697K25.84%414K-20.11%286K
Change In working capital -172.95%-7.59M1,902.16%15.01M185.43%3.52M680.53%1.1M-100.74%-17K787.97%10.41M67.81%-833K-744.06%-4.12M95.88%-190K21.97%2.3M
-Change in receivables -95.41%454K175.94%9.05M96.18%-458K-1,808.20%-1.04M--671K109,711.11%9.88M-843.33%-11.92M-3,819.28%-11.99M256.41%61K--0
-Change in prepaid assets -1,624.43%-7.55M-72.21%622K-81.48%632K173.92%1.48M-202.01%-1.05M-137.12%-438K166.25%2.24M2,646.27%3.41M29.38%-2.01M56.38%-349K
-Change in payables and accrued expense 78.43%-228K-51.61%3.26M81.86%3.39M-49.55%893K-98.69%38K-589.35%-1.06M14,242.55%6.74M935.00%1.86M217.06%1.77M-0.28%2.89M
-Change in other current liabilities -113.13%-265K-1.75%2.07M-101.65%-43K-1,337.50%-230K237.24%328K966.52%2.02M345.18%2.11M1,239.91%2.6M92.69%-16K-13.81%-239K
Cash from discontinued investing activities
Operating cash flow -3,693.22%-22.38M20.69%-33.22M-6.68%-11.06M22.16%-9.56M-31.73%-12.01M94.17%-590K-26.64%-41.89M-28.23%-10.37M-7.07%-12.28M-18.53%-9.12M
Investing cash flow
Cash flow from continuing investing activities 96.45%-1.36M-142.60%-20.13M791.35%17.82M-78.77%4.38M-141.68%-4.16M-360.99%-38.17M151.60%47.25M104.05%2M239.06%20.65M350.91%9.97M
Net PPE purchase and sale 98.64%-17K-187.28%-4.2M98.48%-17K-33.89%-557K-4,390.57%-2.38M-1,088.89%-1.25M-929.58%-1.46M-3,596.88%-1.12M-581.97%-416K44.79%-53K
Net investment purchase and sale 96.37%-1.34M-132.70%-15.93M472.00%17.84M-76.55%4.94M-117.72%-1.78M-354.66%-36.93M153.28%48.71M106.31%3.12M242.45%21.07M358.48%10.02M
Cash from discontinued investing activities
Investing cash flow 96.45%-1.36M-142.60%-20.13M791.35%17.82M-78.77%4.38M-141.68%-4.16M-360.99%-38.17M151.60%47.25M104.05%2M239.06%20.65M350.91%9.97M
Financing cash flow
Cash flow from continuing financing activities -84.38%7.73M1,115.01%66.23M557.30%6.03M-10.99%2.68M20,458.97%8.02M3,242.07%49.5M-95.05%5.45M3,178.57%918K-96.41%3.01M-96.93%39K
Net issuance payments of debt -83.33%-121K-496.97%-394K-74.24%-115K---108K---105K---66K---66K---66K--0--0
Net common stock issuance -84.16%7.85M1,115.63%66.52M546.46%6.11M-7.40%2.79M23,600.00%8.06M3,248.78%49.56M-95.02%5.47M4,873.68%945K-96.41%3.01M-97.31%34K
Proceeds from stock option exercised by employees ----133.33%105K2.56%40K--0---------38.36%45K333.33%39K--0-16.67%5K
Cash from discontinued financing activities
Financing cash flow -84.38%7.73M1,115.01%66.23M557.30%6.03M-10.99%2.68M20,458.97%8.02M3,242.07%49.5M-95.05%5.45M3,178.57%918K-96.41%3.01M-96.93%39K
Net cash flow
Beginning cash position 97.99%26.03M462.76%13.15M-35.73%13.24M70.68%15.73M186.88%23.88M462.76%13.15M-86.22%2.34M-65.52%20.6M320.48%9.22M-33.87%8.32M
Current changes in cash -249.11%-16.01M19.17%12.88M271.63%12.79M-121.91%-2.49M-1,012.43%-8.15M79.26%10.73M173.96%10.81M87.02%-7.45M-80.22%11.38M108.59%893K
End cash Position -58.03%10.02M97.99%26.03M97.99%26.03M-35.73%13.24M70.68%15.73M186.88%23.88M462.76%13.15M462.76%13.15M-65.52%20.6M320.48%9.22M
Free cash flow -1,119.88%-22.4M13.99%-37.44M3.56%-11.08M20.39%-10.12M-57.09%-14.41M81.93%-1.84M-30.84%-43.53M-41.76%-11.49M-10.20%-12.71M-17.75%-9.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg